CELZ vs BIIB: Which Stock is Better?
Side-by-side comparison of Creative Medical Technology Holdings Inc and Biogen Inc in 2026
CELZ
Creative Medical Technology Holdings Inc
$2.47
BIIB
Biogen Inc
$177.35
Key Metrics Comparison
| Metric | CELZ | BIIB | Winner |
|---|---|---|---|
| Market Cap | $8.61M | $25.83B | BIIB |
| P/E Ratio | N/A | 20.05 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | 0.0% | -0.1% | BIIB |
| Gross Margin | 63.4% | 78.9% | BIIB |
Analyze CELZ
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CELZ or BIIB a better investment?
Comparing CELZ and BIIB: Creative Medical Technology Holdings Inc has a market cap of $8.61M while Biogen Inc has $25.83B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CELZ and BIIB?
CELZ (Creative Medical Technology Holdings Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CELZ or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CELZ or BIIB?
CELZ has higher revenue growth at 0.0% vs -0.1% for BIIB.
Which company is more profitable: CELZ or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 63.4% for CELZ.
Which is the larger company: CELZ or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $25.83B compared to $8.61M for CELZ.
Should I buy CELZ or BIIB in 2026?
Both CELZ and BIIB have investment merit. CELZ trades at $2.47 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CELZ and BIIB stock?
Key differences: Market Cap ($8.61M vs $25.83B), P/E Ratio (N/A vs 20.0x), Revenue Growth (0.0% vs -0.1%), Gross Margin (63.4% vs 78.9%).